MINNEAPOLIS—Nonin Medical, a provider of noninvasive medical monitoring solutions, announced that its board of directors has appointed medical device industry leader Todd Austin as the company’s next chief executive officer.
Austin brings extensive experience across strategic planning and execution, business development, external partnerships, product portfolio management, marketing and clinical operations.
“Todd’s deep expertise in respiratory diagnostics and proven record of strategic leadership make him the ideal person to guide Nonin into its next phase of growth,” said Phil Isaacson, executive chairman, board of directors at Nonin Medical. “His passion for innovation in the respiratory medical device industry and commitment to advancing patient outcomes align perfectly with Nonin’s mission and values.”
The company said it looks forward to working closely with Austin as he leads Nonin in expanding its global reach and strengthen partnerships across the health care ecosystem.
Prior to joining Nonin Medical, Austin served as president and CEO of MGC Diagnostics, a subsidiary of CAIRE Inc. and Niterra. Prior to that, he held the role of executive vice president, global marketing, engineering and corporate strategy at MGC Diagnostics. His career also includes leadership roles at Angeion, CareFusion, NDD, VIASYS Healthcare and SensorMedics. In addition to his industry background, Austin is a registered respiratory therapist, registered pulmonary function technologist and neonatal-pediatric specialist.
“Throughout my 30-plus years as a respiratory therapist, I’ve trusted and relied on Nonin’s products and technology across nearly every care setting—from bedside and critical care to transport, sleep and cardiopulmonary diagnostics, remote monitoring and device integration,” said Austin. “Nonin has always stood for quality, reliability and innovation, values that have guided my own career."